PATENTS
Dr.
Allen received the first patent
granted worldwide on the Glycemic Index, and conducts Human
Glycemic In Vivo Clinical Trials for the food, Nutraceutical,
and Pharmaceutical industry. www.GlycemicIndexTesting.com
Dr.
Allen's Patents span over two decades, and have been featured
on the front page of the Wall Street Journal, and named
"Breakthrough Product of the Year" by Success
magazine. (click
for patents section).
FUTURE-SCIENCE
The
medical and research community states that Dr. Allen's science
and technology is "Twenty years ahead of everyone else."
Known
in the industry for her bold stance of setting high standards
in scientific accuracy, Dr. Allen went so far as to correct
Discover magazine, whose educational publication is considered
the gold standard in science. Her statement on quaternary
saturated amines prompted a correction by Discover.
For
over twenty years, Dr. Allen had warned of the dangers of
using L-arginine without a Blind Amino Acid ® Rider. Her
stance on L-arginine was validated in January 2006, when the
Journal of the American Medical Association (JAMA) published
the Johns Hopkins clinical trial on oral L-arginine, in which
L-arginine was shown to cause death in a significant segment
of the subjects, which prompted the close of the clinical
trial. (www.ArginineAnswers.com)
As
a result of her long-term research on the amino acid L-arginine,
the medical and scientific community refered to Dr. Allen
as the Leader in L-Arginine Biochemistry, and the Queen of
Arginine. The Biology Dictionary selected Dr. Allen’s
definition of L-arginine as their standard.
(www.biology-online.org/dictionary/Arginine)
When
Dr. Allen was asked by the media how she is able to stay on
the leading edge of future-science, she replied:
“Part
science, part skill, and part intuition. I also credit my
savant-dyslexia. A dyslexic’s nonlinear images allows
them to think much more quickly and multi-dimensionally. Albert
Einstein was savant-dyslexic. Einstein was able to develop
his theory of relativity due to his dyslexic properties of
creativity and ability to make intuitive leaps. Intuitive
leaps allow me to ignore conventional science and make theoretical
bonds with nutritional concepts. The key then, is to scientifically
prove these concepts.”
As
a tribute to Einstein, in 1983 Dr. Allen named her L-Arginine
Isoform Pathway L-Arginine M². |
